Hamilton Lane (NASDAQ:HLNE) Issues Quarterly Earnings Results

Key Points

• Hamilton Lane beat earnings expectations: Quarterly EPS was $1.98, above the $1.65 analyst consensus and up from $1.54 a year earlier. Revenue rose 7.1% year over year to $204.43 million, though it fell short of the $215.23 million estimate.
• Shares traded near $87.65 after declining modestly, well below the 12-month high of $155.66. The company reported a 32.14% net margin and 25.10% return on equity.
• Analysts remain generally positive: Seven analysts rate HLNE a Buy and three rate it a Hold, producing a “Moderate Buy” consensus and an average price target of $124.12, despite several recent target reductions.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $1.98 earnings per share for the quarter, beating analysts' consensus estimates of $1.65 by $0.33, Zacks reports. Hamilton Lane had a return on equity of 25.10% and a net margin of 32.14%. The firm had revenue of $204.43 million during the quarter, compared to analyst estimates of $215.23 million. During the same quarter last year, the business posted $1.54 earnings per share. The business's quarterly revenue was up 7.1% compared to the same quarter last year.

Hamilton Lane Price Performance

Shares of HLNE traded down $0.19 during trading hours on Tuesday, hitting $87.65. 125,214 shares of the stock were exchanged, compared to its average volume of 766,634. The stock's 50-day moving average price is $90.63 and its two-hundred day moving average price is $97.80. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.49 and a current ratio of 3.49. The company has a market cap of $4.87 billion, a price-to-earnings ratio of 13.34 and a beta of 1.23. Hamilton Lane has a 12-month low of $71.88 and a 12-month high of $155.66.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on HLNE shares. BMO Capital Markets dropped their price objective on shares of Hamilton Lane from $116.00 to $95.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 27th. Zacks Research lowered shares of Hamilton Lane from a "strong-buy" rating to a "hold" rating in a report on Monday, October 19th. Keefe, Bruyette & Woods lifted their price target on Hamilton Lane from $105.00 to $116.00 and gave the company an "outperform" rating in a research report on Wednesday, August 5th. Oppenheimer decreased their price target on Hamilton Lane from $182.00 to $181.00 and set an "outperform" rating for the company in a report on Thursday, August 27th. Finally, UBS Group decreased their price target on Hamilton Lane from $131.00 to $115.00 and set a "buy" rating for the company in a report on Tuesday, October 13th. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $124.12.

Hamilton Lane Company Profile

Hamilton Lane Incorporated NASDAQ: HLNE is a global investment management firm specializing in private markets. The company provides investment solutions and advisory services focused on alternative assets, including private equity, private credit, venture capital, growth equity, infrastructure and real assets.

Hamilton Lane serves institutional investors, family offices, financial advisors and high-net-worth individuals. Its offerings include separately managed accounts, customized portfolios, commingled funds, evergreen vehicles and secondary-market strategies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.